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Although some physiological functions of kainate receptors (KARs) still remain unclear, recent advances have highlighted a role in
synaptic physiology. In hippocampal slices, kainate depresses GABA-mediated synaptic inhibition and increases the firing rate of inter-
neurons.However, the sensitivity to agonists of these responses differs, suggesting that the presynaptic and somaticKARshave a distinct
molecular composition. Hippocampal interneurons express several distinct KAR subunits that can assemble into heteromeric receptors
with a variety of pharmacological properties and that, in principle, could fulfill different roles. To address which receptor types mediate
each of the effects of kainate in interneurons, we used new compounds and mice deficient for specific KAR subunits. In a recombinant
assay, 5-carboxyl-2,4-di-benzamido-benzoic acid (NS3763) acted exclusively on homomeric glutamate receptor subunit 5 (GluR5),
whereas 3S,4aR,6S,8aR-6-((4-carboxyphenyl)methyl) 1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid (LY382884) antago-
nizedhomomericGluR5andanyheteromeric combination containingGluR5 subunits. Inhippocampal slices, LY382884, butnotNS3763,
was able to prevent kainate-induced depression of evoked IPSC. In contrast, neither prevented the concomitant increase in spontaneous
IPSC frequency. The selectivity of these compounds was seen additionally in knock-out mice, such that they were inactive in GluR5/
mice but completely effective in GluR6/ mice. Our data indicate that in wild-type mice, CA1 interneurons express heteromeric
GluR6–KA2 receptors in their somatic compartments and GluR5–GluR6 or GluR5–KA2 at presynaptic terminals. However, functional
compensation appears to take place in the null mutants, a new pharmacological profile emerging more compatible with the activity of
homomeric receptors in both compartments: GluR5 in GluR6/mice and GluR6 in GluR5/mice.
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Introduction
Kainate receptor (KAR) subunits form a class of glutamate recep-
tors that are widely distributed in the brain. Although the physi-
ological role of these receptors is still not absolutely clear, recent
advances have highlighted the kind of functions that they might
play in the brain. Indeed, after the discovery that the 2,3 benzo-
diazepine GYKI53655 was a specific antagonist of AMPA recep-
tors (Paternain et al., 1995; Wilding and Huettner, 1995), func-
tional studies showed that KARs play a significant role in both
synaptic transmission and synaptic plasticity (for review, see Le-
rma, 2003). The activation of KARs modulates neurotransmitter
release from a number of hippocampal synapses, including
GABA release at inhibitory terminals that synapse with CA1 py-
ramidal cells (Clarke et al., 1997; Rodriguez-Moreno et al., 1997;
Bureau et al., 1999) (but see Cossart et al., 1998; Frerking et al.,
1998; Jiang et al., 2001). Indeed, this effect on GABA release is
very much in keeping with the presumptive role of these recep-
tors in epilepsy (Ben-Ari, 1985) (for review, see Lerma et al.,
2001).
Kainate receptors are assembled from five different subunits,
glutamate receptor subunits 5–7 (GluR5–GluR7), KA1, andKA2.
Although GluR5–GluR7 can form functional homomeric recep-
tor channels, KA1 and KA2 must form heteromers with these
GluR subunits to form receptors with distinct properties (Herb et
al., 1992). AlthoughCA1 interneuronsmostly express GluR5 and
GluR6 subunits (Bureau et al., 1999; Paternain et al., 2000), KA2
may also be present in these cells (Wisden and Seeburg, 1993;
Bureau et al., 1999). The activation of theseKARs in hippocampal
interneurons produces two distinct effects on pyramidal cells: an
increase in spontaneous IPSCs, indicative of the depolarization of
the somatodendritic compartments in interneurons; and a re-
duction in the amplitude of evoked IPSC, probably produced by
a depression of GABA release. Hence, it seems possible that at
least two different populations of receptors exist in CA1 inter-
neurons (Rodriguez-Moreno et al., 2000).
Although some studies have shed light on the functional KAR
subunits in hippocampal interneurons (Clarke et al., 1997; Cos-
sart et al., 2001; Mulle et al., 2000), there has been no definitive
demonstration of which subunits may be responsible for modu-
lating neuronal excitability. Therefore, we took advantage of the
development of subunit selective compounds and the availability
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ofmice deficient for KAR subunits to determine the contribution
of receptors with different subunit composition to interneuron
depolarization and to the modulation of GABA release in the
hippocampal CA1 region. Our results show that CA1 interneu-
rons that make synapses with pyramidal neurons express hetero-
meric GluR6–KA2 in the somatic compartments and GluR5–
GluR6 or GluR5–KA2 at presynaptic terminals. However, the
pharmacological profile of KAR-mediated activity is altered in
knock-out (KO)mice. Indeed, it appears that in GluR6/mice,
homomeric GluR5 receptors form both in the soma and at ter-
minals, whereas in GluR5/mice, homomeric GluR6 receptors
are found. These results indicate a functional compensation in
the interneurons of KOmice, such that we must exercise caution
when interpreting results frommice in which KAR subunits have
been deleted.
Materials andMethods
Transient cDNA transfection. Plasmids encoding the GluR6 (VCR or
VCQ versions), GluR5-2a (Q or R form), and KA2 were a gift from Dr.
P. H. Seeburg (Max-Planck Institute, Heidelberg, Germany). The plas-
mids were cotransfected with an enhanced green fluorescent protein
expression vector into human embryonic kidney 293 (HEK293) cells by
electroporation (gene pulser; Bio-Rad, Hercules, CA) or using Lipo-
fectamine PLUS (Invitrogen, Carlsbad, CA). The GluR5 and KA2 plas-
mids were cotransfected in 1:1 or 1:3 ratios, whereas a ratio of 1:2.5 was
used for GluR6 and GluR5 and 1:10 when GluR6 was cotransfected with
KA2. These ratios were sufficient for GluR6 to generate a large propor-
tion of heteromeric receptors with GluR5 and KA2 subunits (Paternain
et al., 2000, 2003). Indeed, this fact was systematically evaluated by ap-
plying AMPA and (RS)-2--amino-3-(3-hydroxy-5-tert-butylisoxazol-
4-yl) propanoic acid (ATPA), which activates heteromeric GluR6–
GluR5 or GluR6–KA2 but not homomeric GluR6. Afterward, the cells
were seeded in Petri dishes in DMEM supplemented with 10% fetal calf
serum and antibiotics, and thenmaintained in a humidified incubator at
37°C and 5% CO2. Highly fluorescent cells were identified and selected
for recording. In our hands, GluR5 (up to 10 g) did not yield any
current when transfected alone (Paternain et al., 2000, 2003). Therefore,
we usedHEK293 cells stably expressing humanGluR5–1a(Q) to evaluate
homomeric GluR5 receptors as described previously (Varming et al.,
2001).
Preparation ofmouse hippocampal homogenates.Hippocampiwere iso-
lated from 2-week-old female GluR5/, GluR6/, and wild-type
(WT) C57 mice. Hippocampi were hand-homogenized with a Teflon-
coated homogenizer in buffer containing 20 mM 3-(N-
morpholino)propanesulfonic acid, pH 7.0, 150 mM KCl, 1% Triton
X-100, and protease inhibitor mixture. The homogenized tissue was in-
cubated on the rotator for 45 min at 4°C to facilitate solubilization of the
proteins. After the solubilization, large membrane fractions were re-
moved by centrifugation at 500  g, and protein concentration was
determined referring to a Bradford colorimetric protein assay with bo-
vine serum albumin as a standard (Bio-Rad). Fifteen micrograms of
proteins from each homogenate were separated by SDS-PAGE, trans-
ferred to nitrocellulose, and used for immunoblotting using established
protocols (Selak et al. 1999). The following antibodies were used: goat
anti-KA2 (N-17; 1:100; Santa Cruz Biotechnology, Santa Cruz, CA), rab-
bit anti-KA2 (C-terminal; 1:3000; Upstate Biotechnology, Charlottes-
ville, VA), and mouse monoclonal antibodies to -actin (1:3000; Sigma,
St. Louis, MO). The intensity of the antibody signal was assessed by
densitometric analysis.
Electrophysiological recordings and perfusion procedures. Electrophysi-
ology experiments were performed 1 d after plasmid transfection in
HEK293 cells. Membrane currents were recorded at a given membrane
potential using the whole-cell configuration of the patch-clamp tech-
nique and using a List Electronics (Darmstadt, Germany) EPC-7 ampli-
fier or aHEKAElektronik (Lambrecht/Pfalz, Germany) EPC-9 amplifier.
Series resistance was compensated by 50–80%, and the patch electrodes
were fabricated from borosilicate glass with a resistance of 5–10 M.
Currents were filtered at 1 kHz (two-pole Butterworth filter, 12 dB/
octave) and transferred at a sampling rate of 1–5 kHz into a personal
computer for analysis and display purposes using pCLAMP software
(Axon Instruments, Foster City, CA) or PULSE software (HEKA Elek-
tronik). All of the experiments were performed at room temperature
(22–25°C). The cells were rapidly perfused using double-barreled appli-
cation pipettes made from theta glass tubes (1.5 mm outer diameter;
World Precision Instruments, Sarasota, FL). The application pipettes
were mounted on a piezoelectric device connected to a piezo driver (PZ-
150M; EXFO, Vanier, Quebec, Canada) driven by transistor–transistor
logic pulses. Alternatively, we used a linear array of eight glass tubes
placed 200–300m from the cell body and driven by amotorized device
under the control of a personal computer (Lerma et al., 1998). Ringer’s
solution with and without drugs flowed from adjacent barrels, and solu-
tion changes were achieved by lateral displacement of the whole perfu-
sion array.
Hippocampal slices were prepared from 14- to 16-d-old mice, as de-
scribed in detail previously (Rodriguez-Moreno et al., 1997). The proce-
dures for handling and killing animals used in this study followed the
European Commission guidelines (86/609/CEE) for handling experi-
mental animals and were supervised by the veterinarian at the Cajal
Institute. Briefly, a hemibrain containing the hippocampus was cut into
300-m-thick sagittal slices with a vibratome slicer (Leica VT1000 S;
Leica Microsistemas, Barcelona, Spain), and the slices were maintained
continuously oxygenated for at least 1 hr before use. Electrophysiological
recordings were performed from neurons visually identified by infrared-
differential interference contrast microscopy using a 40 water immer-
sion objective. All of the experiments were performed at room tempera-
ture (22–25°C). The slices were continuously perfused with a solution of
the following (in mM): 124 NaCl, 2.69 KCl, 1.25 KH2PO4, 4 MgCl2, 2
CaCl2, 26 NaHCO3, and 10 glucose, pH 7.3 (300 mOsm), supplemented
with 25MLY303070 (i.e., the active isomer ofGYKI53655) andAPV (50
M). Drugs were applied by gravity, switching between perfusion lines.
IPSCs were evoked by electrical pulses applied to the stratum oriens by a
bipolar electrode. Tight-seal (1 G) whole-cell recordings were ob-
tained from the cell body of pyramidal neurons. Patch electrodes were
made from borosilicate glass and had a resistance of 3–6Mwhen filled
with the following (inmM): 122CsCl, 8NaCl, 10HEPES, 5 EGTA, and 10
TEA, pH 7.3 (287 mOsm), supplemented with 5 mM lidocaine N-ethyl
bromide (QX314; Alomone Laboratories, Jerusalem, Israel). Under these
conditions, the high concentrations of chloride in the pipette caused the
IPSC to appear as an inward current. Neurons were voltage-clamped
using anAxopatch 200A amplifier (Axon Instruments). Access resistance
(8–30 M) was regularly monitored during recordings, and cells were
rejected if it changed15% during the experiment. Data were filtered at
2 kHz, digitalized, and stored on a computer using the LTP114J software
developed by Bill Anderson (Anderson and Collingridge, 2001) (http://
www.ltp-program.com). Statistical differences were evaluated by the
two-tailed unpaired Student’s t test.
Kainate was obtained from either Ocean Produce International
(Dartmouth, Nova Scotia, Canada) or Tocris Cookson (Bristol, UK).
Disodium glutamate and other salts were obtained from either Sigma
or Merck (Darmstadt, Germany). ATPA and 5-carboxyl-2,4-
di-benzamido-benzoic acid (NS3763) were a gift from Dr. J. Drejer
(NeuroSearch, Ballerup, Denmark); LY303070 was provided by Eli
Lilly (Indianapolis, IN) or custom-synthesized by ABX Logistics
(Radeberg, Germany). 3S,4aR,6S,8aR-6-((4-Carboxyphenyl)methyl)
1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid
(LY382884) was a generous gift from Eli Lilly.
Results
Two compounds have been described recently: LY382884 and
NS3763, which appear to show certain specificity for KARs with
different subunit compositions (Bortolotto et al., 1999; Smolders
et al., 2002; Alt et al. 2004; Christensen et al., 2004). To confirm
that this was the case, we characterized these compounds
in HEK293 cells expressing different combinations of KAR
subunits. Both NS3763 and LY382884 effectively antagonized
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glutamate-induced responses in cells stably expressing homo-
meric GluR5 receptors, although LY382884 was the more potent
antagonist of the two (Fig. 1). However, NS3763 specifically in-
hibited homomeric GluR5 because it was completely ineffective
at 10 M on heteromeric GluR5 receptors that incorporated ei-
ther GluR6 or KA2 (Fig. 1A). In contrast, LY382884 still pre-
vented the activation of heteromeric GluR5 receptors. Neither
compound acted on receptors that did not contain GluR5 (i.e.,
GluR6 and GluR6–KA2) (Fig. 1B).
We did not detect responses after transient transfection of
GluR5 in HEK293 cells. However, when the same plasmid was
cotransfected with either GluR6 or KA2, functional receptors
were formed. Therefore, any response to kainate in cells trans-
fected with GluR5 and KA2 subunits must be via heteromeric
receptors because KA2 subunits do not form homomeric chan-
nels. Thus, the contribution of homomeric GluR5 complexes to
the action of drugs under study could be discarded. However,
functional GluR6 homomers could still coexist with GluR5–
GluR6 or GluR6–KA2 receptors in cells cotransfected with
GluR6 and either GluR5 or KA2.We estimated the relative abun-
dance of GluR6–KA2 heteromers as described previously (i.e.,
looking at the ratio of responses to AMPA and glutamate) (Pa-
ternain et al., 2003) and by the sensitivity of these cells to ATPA
(Fig. 1C). LY382884 andNS3763were inactive on these responses
regardless of the ratio found. The formation of GluR5–GluR6
heteromeric complexes was analyzed by observing the ATPA-
induced responses (Fig. 1A). In these experiments, the fraction of
glutamate-induced current desensitized by a high concentration
of ATPA could be used to estimate the fraction of heteromeric
GluR5–GluR6 receptors (Paternain et al., 2000) because this ag-
onist is inactive on homomeric GluR6 but desensitizes hetero-
meric GluR5 and GluR6. Heteromeric complexes were estimated
to be responsible for80% of the current in these experiments,
and althoughNS3763 did not act on these channels, the degree of
inhibition induced by LY382884 was corrected accordingly.
Therefore, we concluded that although LY382884 antagonizes
native receptors containing GluR5 subunits (Alt et al., 2004),
NS3763 would only act on homomeric GluR5 receptors (Chris-
tensen et al., 2004).
The double action of kainate on CA1 interneurons
We indicated previously that at least two populations of KARs
exist in CA1 interneurons: one presumably located in the soma-
todendritic compartment and the other at synaptic terminals
(Rodriguez-Moreno et al., 2000). In the presence of the selective
AMPA receptor antagonist LY303070 (25 M) and the NMDA
receptor antagonist APV (50 M), activation of interneuronal
somatodendritic KARs can be detected through the frequency of
spontaneous IPSCs (sIPSCs) in CA1 pyramidal cells (Cossart et
al., 1998; Frerking et al., 1998; Rodriguez-Moreno et al., 2000).
The activation of presynaptic KARs can be evaluated by the de-
gree of depression of evoked IPSCs (eIPSCs). Indeed, a 2 min
perfusion of kainate (3 M) provoked an increase in the fre-
quency of sIPSCs (Fig. 2A,C) and a reduction of the peak ampli-
tude of eIPSCs (Fig. 2B,C). Similarly, there was an increase in the
holding current (122 12 pA;n 5) (Fig. 1A), whichwasmostly
a result of the postsynaptic summation of sIPSCs because it was
mostly prevented, although not eliminated (16 3 pA remained;
n  5), by TTX. The effect of kainate was reversible, and sIPSC
frequency, eIPSC amplitude, and the holding current returned to
near control levels after the removal of the agonist. All of these
parameters were also evaluated in hippocampal slices prepared
frommice deficient for eitherGluR5 (Mulle et al., 2000) orGluR6
(Mulle et al., 1998). Interestingly, the basal spontaneous activity
(i.e., sIPSC frequency) was essentially identical in the KO (6.8
1.3 Hz; n  7; and 4.8  0.8 Hz; n  6, in GluR5/ and
Figure 1. Sensitivity of homomeric and heteromeric kainate receptors to the NS3763 and
LY382884 antagonists.A, Examples of current responses in HEK293 cells transiently transfected
with GluR5 and either KA2 or GluR6 and in cells stably transfected with GluR5 alone. Inset,
Response induced by ATPA (100 M), revealing the presence of heteromeric GluR5–GluR6
receptors in the membrane. The rapid application of 1 mM glutamate in the presence (gray
trace) and absence (black trace) of the antagonist is denoted by horizontal bars. B, Summary of
the effect of 10MNS3763 or LY383884 on kainate receptors of different subunit composition.
The amplitudes of the responses in thepresenceof the antagonist are expressedas apercentage
of the responsesobtainedby theapplicationof 1mMglutamate in its absence. Thevalues are the
mean SEM of 4–12 separate experiments. C, Heteromeric GluR6–KA2 but not homomeric
GluR6 receptors are sensitive to micromolar concentrations of the agonist ATPA.
Figure 2. Effect of kainate receptor activation on spontaneous and evoked IPSCs recorded
from CA1 pyramidal cells. A, IPSCs were evoked by paired pulses applied to the stratum oriens
(arrows; 40 msec interval), in the presence of antagonists of NMDA (APV; 50M) and AMPA
(LY303070; 25M) receptors. Black and gray traces correspond to readings before and during
kainate (3M) perfusion, respectively. B, The evoked IPSCs are superimposed after subtracting
the holding current. C, Time course of evoked IPSC amplitudes (filled circles) and frequency
(unfilled circles), before, during, andafter kainate application. Points are themeanSEMof14
experiments.D,Meanbasal frequency of spontaneous IPSCs inwild-type andGluR5 or GluR6KO
mice. The spontaneous IPSC frequency was computed for a 3 min segment in each cell from
6–14 separate experiments. The columns represent the mean SEM.
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GluR6/ mice, respectively) and wild-type (4.8  0.6 Hz; n 
14) mice (Fig. 2D).
Characteristics of kainate receptors mediating the increase of
sIPSC frequency
Exposure to kainate (3 M) increased the frequency of sIPSCs to
a similar extent in both WT and GluR5/ neurons (16 1 Hz;
n 14; and 18 1.3 Hz; n 7, respectively) (Fig. 3A,B). How-
ever, kainate was less efficient in inducing this increase in sIPSC
frequency in neurons from GluR6/ mice (8.0  2 Hz; n  6;
p 0.005) (Fig. 3A,B). We also analyzed the effects of applying
ATPA, an agonist that activates receptors containing GluR5. In
WT slices, the active isomer S-ATPA (10 M) moderately in-
creased sIPSC frequency (7  2 Hz; n  9) (Fig. 3B), which in
principle could indicate the existence of receptors containing
GluR5 subunits in the somatodendritic compartment. A similar
effect was produced by S-ATPA in slices fromGluR6/ animals
(11  3 Hz; n  8) but not in slices prepared from GluR5-
deficient mice. We then studied the effect of the antagonists
NS3763 and LY382884 on the responses mediated by receptors
situated in the somatodendritic compartment. In WT animals,
LY382884 and NS3763 were unable to antagonize the kainate-
induced increase in sIPSC frequency, a characteristic also ob-
served in GluR5 KO mice (Fig. 3C). However, both antagonists
severely reduced the increase in sIPSC frequency inmice inwhich
the GluR6 subunits were deleted. In the presence of NS3763, the
kainate-induced increase in sIPSC frequency was prevented by
89  14% (n  6), whereas LY382884 almost completely abol-
ished this response by 95 2% (n 5) (Fig. 3C).
The failure of LY382884 to inhibit the kainate-induced in-
crease of sIPSC frequency in WT mice, coupled to the antago-
nism of all of the recombinant receptors containing GluR5 sub-
units, rules out the possible existence of receptors containing
GluR5 in the somatodendritic compartment of WT CA1 inter-
neurons. However, it has been shown that 10 M ATPA is active
on heteromeric receptors made up of GluR6 and KA2 (Fig. 1C)
(Paternain et al., 2000; Alt et al. 2004). To further assess the
presence of heteromeric GluR6–KA2 at the somatodendritic
compartment and that the action of ATPA on the frequency of
sIPCS was mainly attributable to activation of this and no other
combination of subunits, we studied whether LY389884 was able
to antagonize the depolarizing action of ATPA. Thus, we mea-
sured the change in holding current induced by bath application
of ATPA (10M) in interneurons in the presence of TTX to avoid
spontaneous firing. Cells laying in the stratumoriens or radiatum
with an ovoid shape were recorded as interneurons. At a holding
potential of60 mV, application of ATPA increased the holding
current in 9 of 11 cells studied by 121.4 23 pA (n 9). Such a
change in holding current was not antagonized by the LY382884
(10 M) (92.4 6% of the current remained) (Fig. 4), ruling out
the possibility that somatodendritic GluR5-containing receptors
are implicated in the action of ATPA. Therefore, the inability to
activate receptors by ATPA in the absence of GluR5 indicates that
the receptors mediating kainate-induced depolarization of inter-
neuron membrane do not contain the KA2 subunit.
These data indicate that functional GluR5-containing KARs
are present in the somatodendritic compartment of CA1 inter-
neurons in GluR6-deficient but not in WT mice. In contrast,
receptors containing GluR6 subunits appear to be present in this
compartment in both WT and GluR5-deficient mice. However,
their sensitivity toATPA indicates that theymust include theKA2
subunit in WT but surprisingly not in GluR5/ mice. Consis-
tent with this assumption, ATPA (10 M) induced no current in
interneuron from the GluR5-deficient mice (data not shown).
Properties of kainate receptors mediating inhibition of GABA
release on CA1 pyramidal neurons
Several studies have shown that the activation of presynaptic
KARs can depress GABAergic synaptic transmission in the rat
hippocampus (Clarke et al., 1997; Rodriguez-Moreno et al., 1997,
2000; Rodriguez-Moreno and Lerma, 1998; Cunha et al., 2000).
This kainate-induced decrease in the amplitude of the eIPSCs has
been reported in wild-type mice as well as in mice lacking either
Figure 3. Effect of antagonists on the increase in the kainate-induced frequency of sponta-
neous IPSCs in wild-type and KO mice. A, Representative recordings before (black traces) and
during (gray traces) kainate (3M) application in the presence and absence of NS3763 (3M).
Traces correspond to different neurons because kainate was applied just once per slice. B,
Increase in spontaneous IPSC frequency induced by kainate and ATPA in wild-type and kainate
receptor KO mice. Bars are the averages of data obtained from 5–14 experiments. C, Effect of
NS3763 and LY382448 on the kainate-induced increase in spontaneous IPSC frequency. The
dotted line represents the effect of kainate (3 M) in the absence of antagonist. *p 0.05;
**p 0.005, two-tailed Student’s unpaired t test.
Figure 4. Effect of LY38288 on ATPA-induced currents in hippocampal interneurons. A, In-
ward currents induced by bath-applied ATPA (10 M) in hippocampal interneurons before
(black trace), during (dark gray trace), and after (light gray trace) application of LY382884 (10
M). LY382884was introduced in the chamber at least 4min before the agonist. Rec, Recovery.
B, Summary of the ATPA-induced responses in the presence of LY382884. The values are the
mean SEM expressed as a percentage of control responses (4 slices).
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the GluR5 or GluR6 subunits (Bureau et al., 1999; Mulle et al.,
2000). We further studied the pharmacology of this KAR-
mediated activity inWT aswell as inGluR5- andGluR6-deficient
mice. Application of 3 M kainate caused a decrease of 42 4%
(n  14) in the amplitude of the eIPSCs in slices prepared from
WT mice (Fig. 5A,B). In accordance with a previous report
(Mulle et al., 2000), kainate also had a similar effect on eIPSC
amplitude in GluR5/ (inhibition of 35  8%; n  8) and
GluR6/ (35 10% depression; n 6) mice (Fig. 5A,B). The
inhibitory action of kainate was not significantly affected by the
presence of NS3763 in WT mice (26  20% reduction; n  14;
p  0.05) (Fig. 5C). However, in the presence of LY382884, the
kainate-induced depression of eIPSCs was reduced by 66 21%
(n  8; p  0.05) (Fig. 5C). As expected, NS3763 or LY382884
had no effect on the kainate-induced depression of eIPSC ampli-
tude in GluR5/ mice but completely abolished the activity of
kainate in GluR6/ mice. Indeed, NS3763 and LY382884 pre-
vented the kainate-induced depression of eIPSC amplitude by
95  9% (n  6) and 85  25% (n  4), respectively, in the
absence of GluR6 (Fig. 5C).
These results indicate that GluR5-containing receptors are
present in the synaptic terminals of CA1 interneurons inWT and
GluR6/ mice. Because NS3763 exclusively inhibits homo-
mericGluR5 receptors in recombinant systems, thesemust be the
receptors assembled in GluR6-deficient terminals. Exposure to
ATPA (10 M) caused a modest but significant reduction of
eIPSC amplitude in WT mice (13  4% inhibition; n  9; p 
0.05). Although such an effect was not observed in GluR5-
deficient mice, it was twofold larger in neurons from GluR6/
mice (27  6%; n  8), which is consistent with the aforemen-
tioned results.
KA2 subunit is downregulated in GluR5- and GluR6-
deficient mice
The data obtained in KOmice indicated a change in the pharma-
cological profile of kainate receptors expressed at both somato-
dendritic and presynaptic compartments, more compatible with
the existence of receptors lacking the KA2 subunit. Therefore, we
decided to study whether this subunit was actually downregu-
lated in mice deficient for either GluR5 or GluR6. Figure 6 shows
the results obtained by Western blot analysis from homogenates
obtained fromhippocampi isolated fromwild-type andKOmice.
KA2 protein was detected by both N- and C-terminal-specific
antibodies. As can be seen, in both cases, KA2 protein is signifi-
cantly reduced in GluR5/mice and almost absent in GluR6/
mice. These results extend and support conclusions achieved
from pharmacological data, in that KA2 subunit protein is pri-
marily downregulated when one of the main subunits, GluR5 or
GluR6, are absent, therefore decreasing the chance to form het-
eromeric kainate receptors.
Discussion
In this study, we show that the subunit composition of native
KARs expressed in the somatodendritic compartment differs
from that in the presynaptic compartment of CA1 hippocampal
interneurons. Although the somatodendritic receptors are
GluR6–KA2 heteromers, presynaptic receptors contain GluR5
and either GluR6 or KA2. Moreover, experiments performed in
mice deficient for either GluR5 or GluR6 demonstrated that in
the absence of one of these subunits, the formation of hetero-
meric receptors was not favored. This is most likely attributable
to a drastic reduction of KA2 subunit levels, as shown byWestern
blotting.
Our conclusions are based on the assumption that 3 M kai-
nate is sufficient to activate all of the types of KAR complexes and
that 10 M ATPA activates both GluR6–KA2 heteromeric recep-
tors and complexes containing GluR5. This has been illustrated
previously (Paternain et al., 2000; Alt et al., 2004) and was con-
firmed in experiments here (Fig. 1C). We also analyzed the activ-
ity of the newly developed KAR antagonists, namely NS3763 and
LY382884. The inhibitory effects of these antagonists on homo-
meric and heteromeric KAR complexes expressed in HEK293
cells were confirmed (Fig. 1). In agreement with previous studies,
NS3763 (10 M) antagonized homomeric GluR5 receptors
(Christensen et al., 2004). Furthermore, we found that this com-
pound acts exclusively on homomeric GluR5 and not on hetero-
meric receptors. In contrast, LY382884 (10M)was active on any
GluR5-containing complex (i.e., GluR5, GluR5–KA2, and
GluR5–GluR6) (Alt et al., 2004). However, when studying the
action of a drug on heteromeric receptors, some caution must be
exercised because mixed populations of homomeric and hetero-
meric receptorsmay coexist in themembrane. In our present and
previous experiments, transient transfection of GluR5 alone did
not generate measurable currents (Paternain et al., 2000, 2003;
Alt et al., 2004), and it is well known that KA2 subunits do not
form functional homomeric receptors (Herb et al., 1992). For
this reason, we excluded any contribution of homomeric GluR5
Figure 5. Effect of kainate receptor antagonists on the kainate-induced reduction of evoked
IPSC amplitude inwild type and KOmice. A, Representative evoked IPSCs before (black records)
andduring (gray traces) application of kainate (3M) in the presence and absence of NS3763 (3
M). Recordings are from different neurons because kainate was applied just once per slice. B,
Inhibitory effects of kainate and S-ATPA on the amplitude of evoked IPSCs in wild-type and KO
animals. C, Effect of kainate receptor antagonists on the kainate-induced inhibition of evoked
IPSCs. The dotted line represents the inhibitory effect induced by kainate in the absence of
antagonists. Bars correspond to themean SEM of 3–14 experiments. *p 0.05, two-tailed
Student’s unpaired t test.
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complexes to glutamate-induced responses in these experiments.
Because the coexistence of functional GluR6 homomers with
GluR5–GluR6 or GluR6–KA2 receptors was possible in cells co-
transfected with GluR5 and GluR6 or GluR6 and KA2, respec-
tively, we estimated the relative abundance of GluR6–KA2 and
GluR5–GluR6 heteromers as described previously (Paternain et
al., 2003). LY382884 and NS3763 were inactive when GluR6 and
KA2 were expressed, whereas the inhibitory action of LY382884
was larger because the estimated fraction of GluR5–GluR6 het-
eromeric receptors was higher.
The conclusions regarding the composition of KARs in inter-
neuronal compartments are essentially illustrated in Figure 7. In
WT animals, the pharmacological profile after the activation of
somatodendritic KARs is similar to that found in heterologous
systems in which GluR6 and KA2 subunits are coexpressed. Al-
though more abundant in pyramidal cells, KA2 subunits are also
expressed by some interneurons in the hippocampus (Bureau et
al., 1999). This is reminiscent of GluR6, which is highly abundant
in principal cells, yet it is also expressed in interneurons (Bureau
et al., 1999; Paternain et al., 2000). Consequently, the formation
of heteromeric GluR6–KA2 subunits seems probable, at least in
one population of interneurons. It therefore seems possible that
in situ hybridizationmight underestimate the expression of these
two subunits in interneurons because receptors made up of both
subunits mediate depolarization of the somatodendritic mem-
brane. In contrast, themodulation ofGABA release (estimated by
the amplitude of eIPSCs) detected in WT animals is consistent
with the presence of heteromeric GluR5 receptors. However, it
was not possible for us to differentiate between GluR5 receptors
associated with KA2 or GluR6 subunits because both heteromers
presented similar agonist and antagonist properties. Indeed, the
possibility remains that both types of receptors coexist in termi-
nals. It should be noted that native KARs may not be identical to
the recombinant heteromeric combinations that we studied. The
existence of native receptors made up of different isoforms of the
subunits that we used but still with similar pharmacological
properties could not be excluded.However, based on present and
previous data, we think that Figure 7 represents the most parsi-
monious conclusion in terms of subunit composition of native
KARs, regardless of the specific isoform involved.
Although there are somedifferences inmagnitude, the datawe
present are comparable with those observed previously in mice
by Bureau et al. (1999) and Mulle et al. (2000). It was clear from
our results, however, that somatodendritic receptors do not cor-
respond to heteromeric GluR5–GluR6 receptors. This is in con-
trast to the conclusion reached by Mulle et al. (2000), deduced
from the observation that kainate responses were only abolished
in the dual GluR5–GluR6 KOmice. Indeed, the capacity of 3 M
kainate to stimulate sIPSCs in WT and GluR5 knock-out mice
was reduced albeit not eliminated in GluR6/ mice (Fig. 3).
Although a reduction in number and/or conductance of somato-
dendritic receptors is possible (Swanson et al., 1996), this is con-
sistent with the observation that the potency of kainate on homo-
meric GluR5 receptors ismuch lower than onGluR6–KA2 (Alt et
al., 2004). The change of pharmacological profile of these re-
sponses indicates thatGluR5 can replace theGluR6 subunit in the
somatodendritic compartment but does not contradict the need
for GluR6 to induce this effect inWT animals. Something similar
happens at the presynaptic terminals: in the absence of GluR5,
GluR6 becomes involved in modulating GABA release. There-
fore, the selective pharmacological profiles in these compart-
ments led us to conclude that such compensatory mechanisms
are at play in these KO mice. In GluR6-deficient mice, both the
increase in sIPSC frequency and the depression of eIPSCs not
only become sensitive to LY382884, as expected, but both were
also effectively antagonized by NS3763, a drug that exclusively
Figure 6. The KA2 subunit is downregulated in GluR5- and GluR6-deficient mice. Western
blot analysis of hippocampal homogenates showed that the protein levels of the KA2 subunit
weremuch lower in both GluR5- andGluR6-deficientmice comparedwithWTmice. The signals
obtained by antibodies directed toward N-terminal (-KA2Nterm ) (A) or C-terminal (-
KA2Cterm ) (B) epitopes of KA2were assessedbydensitometric analysis. Densitometryprofiles of
immunoblots are shown for each case. -Actin was used as a loading control in each case.
Calibration: KA2 blots, 0.02 arbitrary units;-actin blots, 0.2 arbitrary units.
Figure 7. Diagram summarizing the deducted subunit composition of somatic and presyn-
aptic kainate receptors in CA1 interneurons from wild-type and KO mice. The table at the bot-
tom summarizes the main activity of agonists and antagonists on the two parameters studied.
1 indicates that the agonist stimulates the receptor,whereas2 indicates that the antagonist
significantly reduced receptor activation; indicates that the compound was inactive in an-
tagonizing or stimulating receptors. Each color represents a particular pharmacological profile.
Note that although inhibition of evoked IPSCs (i.e., presynaptic activity) presents a profile com-
patible with both heteromeric GluR5–GluR6 (green) and GluR5–KA2 (cream) receptors, the
behavior of the IPSC frequency (i.e., somatodendritic receptor activity) only fits with the het-
eromeric GluR6–KA2profile (light blue). The situation is drastically altered in KOmice, inwhich
the corresponding pharmacological profiles exclusively match profiles of homomeric receptors
(yellow or blue).
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acts on homomeric GluR5 receptors. In contrast, and as expected
in GluR5-deficient mice, LY382884 and NS3763 were unable to
antagonize the kainate-induced increase of sIPSC frequency or
depression of eIPSC amplitude, but these effects were not in-
duced by ATPA. This lack of sensitivity to ATPA indicates that
GluR6–KA2 heteromeric receptors are not present in the inter-
neurons of GluR5/ mice. Therefore, the results imply that
compensatory mechanisms exist in which one KAR subunit may
substitute for the other in hippocampal interneurons. Although
there are many examples of functional compensation after gene
inactivation, what it is remarkable in the present case is that the
absence of one of these subunits precludes the formation of het-
eromeric receptors by the others. Western blot analysis indicated
that the KA2 protein was drastically downregulated in the hip-
pocampus of GluR6 and GluR5 KO mice. The exact mechanism
remains unknown, and we ignore whether this is a compensative
process or whether it results from the route that subunits follow
to assemble into heteromeric receptors. However, this appears
reminiscent of the situation observed for GABA receptors. In
cerebellar granule cells from 6-deficient mice, a perturbation
of other subunits takes place, and the  subunit is degraded
(Jones et al., 1997). This is a phenomenon beyond functional
compensation, and it will be necessary to perform additional
studies to determine the exact mechanism by which this takes
place.
The somatodendritic receptors inmice (i.e., sIPSC frequency)
were less sensitive toATPA than to kainate, which is in contrast to
what has been found in rats (Cossart et al., 1998; Rodriguez-
Moreno et al., 2000). This might indicate that there are differ-
ences in receptor and/or isoform composition between species.
Alternatively, the agonist sensitivity of orthologous subunits may
differ among animal species, as has been found for recombinant
GluR5 receptors of human and rat origin. In this case, human
GluR5 receptors are much less sensitive to activation by domoate
than those from rat (Alt et al., 2004).
Finally, we would like to emphasize the notion that KARmo-
saics exist in hippocampal interneurons, each playing a different
role. Although somatodendritic depolarization is mediated by
GluR6–KA2 heteromers, modulation of GABA release involves
receptors containing theGluR5 subunit (Clarke et al., 1997). This
further emphasizes the existence of KARs at presynaptic
GABAergic terminals controlling GABA release in a specific, di-
rect, and regulated way. Interestingly, the segregation of KARs
should allow us to design drugs to specifically target one function
or another, producing drastically different effects. For instance,
the specific activation of somatodendritic KARs at interneurons
may result in a strong inhibition of principal cells (Khalilov et al.,
2002). In contrast, antagonism of somatic receptors would re-
duce the inhibition of pyramidal neurons, whereas the antago-
nism of presynaptic receptors would potentiate it, probably pro-
ducing an antiepileptic effect. Along these lines, recent results
showed that LY382884 and other GluR5 antagonists behave as
potent antiepileptic compounds in a model of hippocampal epi-
lepsy (Smolders et al., 2002).
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